Salman M Albeshan, Maha M Almuqbil, Mahoud M Elsharkawi, Hifa Nassri, Nuha A Khoumais
{"title":"Outcomes of the Saudi breast cancer early detection program: a nine-year analysis (2012-2020).","authors":"Salman M Albeshan, Maha M Almuqbil, Mahoud M Elsharkawi, Hifa Nassri, Nuha A Khoumais","doi":"10.1007/s10549-025-07633-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study aims to report the preliminary outcome of the Saudi breast cancer early detection program (SBCEDP).</p><p><strong>Methods: </strong>Mammography screens were done for Saudi women (age 40-69 years old) who participated in the SBCEDP from April 2012 to December 2020. Independent double-blind reading of the mammograms was performed by two radiologists. Analysis of age at diagnosis, cancer characteristics, and available screening indicators will be reported within this timeframe.</p><p><strong>Results: </strong>Among 72,774 screened women, 504 had breast cancer cases, yielding a cancer detection rate of 6.93 per 1000 screened women. DCIS detection rate was 0.87 per1000 screened women (n = 63). Mean age at diagnosis was 53.61 years (SD = 8.85) and the majority women had fatty breast tissue (A and B, 65%). Luminal A subtype was predominant (N = 58.6%), whereas triple-negative breast cancers constituted about 12.6% of cases. Estrogen and progesterone positivity was common (more than 65% of cases). Early and localized breast cancer was reported among 28% and 45.8% of women, respectively. Lesions mean size was 23.88 mm and mastectomy rate was 54.2%.</p><p><strong>Conclusion: </strong>Although not all screening indicators were available, the SBCEDP demonstrates encouraging results, with notable rates of early-stage diagnosis. Continuous evaluation and improvement of screening strategies are essential for further enhancing the program effectiveness in reducing breast cancer mortality and morbidity among Saudi women.</p>","PeriodicalId":9133,"journal":{"name":"Breast Cancer Research and Treatment","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Breast Cancer Research and Treatment","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10549-025-07633-6","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: This study aims to report the preliminary outcome of the Saudi breast cancer early detection program (SBCEDP).
Methods: Mammography screens were done for Saudi women (age 40-69 years old) who participated in the SBCEDP from April 2012 to December 2020. Independent double-blind reading of the mammograms was performed by two radiologists. Analysis of age at diagnosis, cancer characteristics, and available screening indicators will be reported within this timeframe.
Results: Among 72,774 screened women, 504 had breast cancer cases, yielding a cancer detection rate of 6.93 per 1000 screened women. DCIS detection rate was 0.87 per1000 screened women (n = 63). Mean age at diagnosis was 53.61 years (SD = 8.85) and the majority women had fatty breast tissue (A and B, 65%). Luminal A subtype was predominant (N = 58.6%), whereas triple-negative breast cancers constituted about 12.6% of cases. Estrogen and progesterone positivity was common (more than 65% of cases). Early and localized breast cancer was reported among 28% and 45.8% of women, respectively. Lesions mean size was 23.88 mm and mastectomy rate was 54.2%.
Conclusion: Although not all screening indicators were available, the SBCEDP demonstrates encouraging results, with notable rates of early-stage diagnosis. Continuous evaluation and improvement of screening strategies are essential for further enhancing the program effectiveness in reducing breast cancer mortality and morbidity among Saudi women.
期刊介绍:
Breast Cancer Research and Treatment provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a "market place" for breast cancer topics which cuts across all the usual lines of disciplines, providing a site for presenting pertinent investigations, and for discussing critical questions relevant to the entire field. It seeks to develop a new focus and new perspectives for all those concerned with breast cancer.